for hims tirzepatide & Hers Weight Loss Alternative | Compounded Semaglutide $199/mo Tirzepatide Injectable – Hims, Inc.

A 2023 observational study found that patients on GLP-1 agonists for more than 6 months should monitor their B12 status

BOTTOM LINE Tirzepatide is highly effective and may be considered for patients desiring significant weight loss who are able to administer weekly subcutaneous injections

Skin Benefits Compared: Glow, Texture, Acne, and Healing L-Glutathione, as a potent antioxidant, is recommended for: Protection against oxidative stress Even a healthier complexion Youthful glow A brighter, radiant skin

For pharma planning teams, the implication is that obesity is now a multi-endpoint, multi-mechanism therapeutic area

Mechanism of Action GLP-1 medications like tirzepatide and semaglutide work in multiple ways, including appetite suppression and improved insulin sensitivity these lead to lower levels of glucose in the blood

The review process under Health Canadas standard pathway takes approximately twelve months, though priority review can reduce this to six to eight months for medications addressing significant unmet needs